Lentiviral vectors encoding clotting factors for gene therapy

   
   

Recombinant lentiviruses and transfer vectors for transgene delivery as well as methods for gene therapy using such vectors are disclosed. The invention provides a third generation lentiviral packaging system and a set of vectors for producing recombinant lentiviruses, as well as novel tissue specific enhancer and promoter elements useful for optimizing liver specific transgene delivery. The transgene is preferably a blood clotting factor such as human factor IX (hFIX) or human factor VIII (hFVIII) and can be used for treatment of hemophilia.

Os lentiviruses e os vetores recombinant de transferência para a entrega do transgene as.well.as métodos para a terapia do gene que usa tais vetores são divulgados. A invenção fornece um sistema empacotando lentiviral de terceira geração e um jogo dos vetores produzindo lentiviruses recombinant, as.well.as os elementos específicos do enhancer e do promoter do tecido da novela úteis para optimizing a entrega específica do transgene do fígado. O transgene é preferivelmente um fator clotting do sangue tal como o fator humano IX (hFIX) ou o fator humano VIII (hFVIII) e pode ser usado para o tratamento do hemophilia.

 
Web www.patentalert.com

< Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection

< Methods for generating genetically altered antibody producing cell lines with improved antibody characteristics

> Treatment of diarrhea with strains of Bifidobacterium longum

> Functionalized porous substrate for binding chemical and biological moieties

~ 00140